Adjuvant Global Health Technology Fund DE, L.P.

Shareholder at ANTX

Sold, on record
$265k
Dollars the filings state
Form 4 sales
2
Latest Sep 28, 2023
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ANTXAN2 Therapeutics, Inc.Shareholder

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ANTXNo plan
    Sep 7, 2023 2023

    Sold 7,140 shares at $16.03 ($114k)

    Adjuvant Global Health Technology Fund DE, L.P., 10% owner

    No 10b5-1 planSold 0.3% of holdings ($35M position)2.2M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ANTXNo plan
    Sep 28, 2023 +21 days

    Sold 9,357 shares at $16.11 ($151k)

    Adjuvant Global Health Technology Fund DE, L.P., 10% owner

    No 10b5-1 planSold 0.4% of holdings ($35.1M position)2.2M shares leftFiling

  3. 3 Form 144 notice ANTXNotice
    Jan 16, 2024 +110 days

    Filed to sell 15,907 shares ($332k)

    Adjuvant Global Health Technology Fund DE, L.P., Shareholder

    No 10b5-1 planFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Adjuvant Global Health Technology Fund DE, L.P.
Source
Jan 16, 2024Jan 16, 2024ANTXShareholderForm 144 notice15,907$332kNoticeSEC
Sep 28, 2023Sep 29, 2023ANTX10% ownerForm 4 sale9,357$151k0.4%No planSEC
Sep 7, 2023Sep 8, 2023ANTX10% ownerForm 4 sale7,140$114k0.3%No planSEC